pyridostigmine bromide
- Product NDC
- 68682-307
- 11-digit product format
- 686820307
- Labeler code
- 68682
- Product ID
- 68682-307_dea0cb1f-7ec8-4f54-968f-8f095fa8ac95
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- pyridostigmine bromide
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Oceanside Pharmaceuticals
- Application
- NDA015193
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2019-07-01
- Substance
- PYRIDOSTIGMINE BROMIDE
- Active strength
- 60 mg/5mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- pyridostigmine bromide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PYRIDOSTIGMINE BROMIDE | 60 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | KVI301NA53 |
| Rxcui | 903843 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68682-307-05 | pyridostigmine bromide | 473 mL in 1 BOTTLE | SOLUTION | 473 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68682-307 | PYRIDOSTIGMINE BROMIDE SOLUTION [OCEANSIDE PHARMACEUTICALS] | 2 | Current NDC, Legacy NDC, 1 package rows | 20210212_970a0191-693c-480b-aeff-9f8956936159.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68682-307-05 | 68682030705 | 473 mL in 1 BOTTLE (68682-307-05) | 473 ml | 2019-07-01 | 0000-00-00 | No | No | Current |